CONNECT BIOPHARMACEUTICALS

connect-biopharmaceuticals-logo

Connect Biopharmaceuticals is a clinical-stage company that discovers and develops novel medicines for the treatment of autoimmune diseases and inflammation. They identify and advance our drug candidates through in-house discovery and in-licensing while leveraging qualified CROs for further development. The company successfully completed a phase I clinical trial study on our leading program CBP-307, a novel and selective second-generation S1P1 (a G-protein coupled receptor -GPCR) modulator for t... he treatment of a range of autoimmune disorders, including multiple sclerosis, inflammatory bowel disease, and psoriasis. Connect Biopharmaceuticals currently conducting two phases 2 clinical studies in patients with ulcerative colitis and Crohn's disease with their lead drug candidate CBP-307. It also concluding a phase 1 study of our second drug candidate CBP-201 in healthy subjects, with a phase 1b study in atopic dermatitis patients expected to commence in Q1, 2019. Connect Biopharmaceuticals was founded in 2012 and is headquartered in Taichang, China.

#SimilarOrganizations #People #Financial #Event #Website #More

CONNECT BIOPHARMACEUTICALS

Industry:
Biotechnology Clinical Trials Health Care Medical Therapeutics

Founded:
2012-01-01

Address:
Taicang, Hebei, China

Country:
China

Website Url:
http://www.connectbiopharm.com

Total Employee:
1+

Status:
Active

Contact:
0512-53577866

Email Addresses:
[email protected]

Total Funding:
195 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

asahi-genomics-logo

Asahi Genomics

Asahi Genomics is into development of clinical testing technology, business related to overcoming diseases and improving / promoting health.


Current Advisors List

derek-dirocco_image

Derek DiRocco Board Member @ Connect Biopharmaceuticals
Board_member
2020-08-01

not_available_image

Xiaoping Ye Board of Director @ Connect Biopharmaceuticals
Board_member

william-hu_image

William Hu Board Member @ Connect Biopharmaceuticals
Board_member

jennifer-jin_image

Jennifer Jin Board of Director @ Connect Biopharmaceuticals
Board_member

Current Employees Featured

zheng-wei_image

Zheng Wei
Zheng Wei Co-founder, CEO @ Connect Biopharmaceuticals
Co-founder, CEO

not_available_image

William Pan
William Pan Co-Founder and President @ Connect Biopharmaceuticals
Co-Founder and President

not_available_image

Jiang Bian
Jiang Bian General Counsel & Chief Compliance Officer @ Connect Biopharmaceuticals
General Counsel & Chief Compliance Officer
2021-08-20

not_available_image

Jeffery White
Jeffery White Chief Medical Officer @ Connect Biopharmaceuticals
Chief Medical Officer

not_available_image

Eric J. Hall
Eric J. Hall CFO @ Connect Biopharmaceuticals
CFO
2021-11-01

Founder


not_available_image

William Pan

zheng-wei_image

Zheng Wei

Stock Details


Company's stock symbol is NASDAQ:CNTB

Investors List

qiming-venture-partners_image

Qiming Venture Partners

Qiming Venture Partners investment in Series C - Connect Biopharmaceuticals

hbm-healthcare-investments-ag_image

HBM Healthcare Investments AG

HBM Healthcare Investments AG investment in Series C - Connect Biopharmaceuticals

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Series C - Connect Biopharmaceuticals

boxer-capital_image

Boxer Capital

Boxer Capital investment in Series C - Connect Biopharmaceuticals

lilly-asia-ventures_image

Lilly Asia Ventures

Lilly Asia Ventures investment in Series C - Connect Biopharmaceuticals

northern-light-venture-capital_image

Northern Light Venture Capital

Northern Light Venture Capital investment in Series B - Connect Biopharmaceuticals

qiming-venture-partners_image

Qiming Venture Partners

Qiming Venture Partners investment in Series B - Connect Biopharmaceuticals

cowin-capital_image

Cowin Capital

Cowin Capital investment in Series B - Connect Biopharmaceuticals

advantech-capital_image

Advantech Capital

Advantech Capital investment in Series B - Connect Biopharmaceuticals

cowin-capital_image

Cowin Capital

Cowin Capital investment in Series A - Connect Biopharmaceuticals

Official Site Inspections

http://www.connectbiopharm.com Semrush global rank: 4.88 M Semrush visits lastest month: 1.8 K

  • Host name: 203.81.160.34.bc.googleusercontent.com
  • IP address: 34.160.81.203
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Connect Biopharmaceuticals" on Search Engine